Cutaneous vasculitis has been associated with both Coronavirus disease-2019 (COVID-19), and SARS-CoV-2 vaccines. We reported a 41-year-old male who developed bullous lesions and erythematous plaques leading to atrophic patches two weeks after injection of the second dose of the COVID-19 vaccine. The skin biopsy showed leukocytoclastic vasculitis. The disease was self-limited and no recurrence of symptoms happened after six months of follow-up.